Eris Lifesciences Limited — Important, 25-10-2024: Financial Result Updates

Eris Lifesciences Limited's Board approved the unaudited financial results for the quarter and half-year ended September 30, 2024, showing a net profit of ₹28.10 crore and a revenue increase. The company also executed a binding term sheet to acquire a 30% stake in Levim Lifetech Private Limited. All financial documents were submitted with unmodified auditor opinions. There were no deviations in the use of funds raised through recent non-convertible debenture placements.